---
title: "Trevi Therapeutics (TRVI.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/TRVI.US/norm.md"
symbol: "TRVI.US"
name: "Trevi Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/TRVI.US.md"
datetime: "2026-05-20T13:54:47.423Z"
locales:
  - [en](https://longbridge.com/en/quote/TRVI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TRVI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TRVI.US/norm.md)
---

# Trevi Therapeutics (TRVI.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0906 | -0.0572 | -0.0813 | -0.0944 | -0.0879 |
| ROE | -29.70% | -17.83% | -24.32% | -33.03% | -41.55% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -13.19M | -8.32M | -11.80M | -12.30M | -10.34M |
| 营业利润 | -14.91M | -10.22M | -13.92M | -13.72M | -11.47M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 179.61M | 193.44M | 199.36M | 208.34M | 107.00M |
| 权益乘数 | 1.04 | 1.06 | 1.05 | 1.05 | 1.08 |
| 每股净资产 | 1.34 | 1.43 | 1.48 | 1.63 | 0.9956 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 171.78M | 188.26M | 194.93M | 203.88M | 103.26M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 875000.00 | 855000.00 | 954000.00 | 1.04M | 1.14M |
| 净债务 | -171.10M | -187.51M | -194.10M | -202.99M | -102.30M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -16.69M | -7.63M | -10.88M | -10.10M | -13.48M |
| 投资现金流 | 16.96M | -30.61M | -50.94M | -2.61M | -9.95M |
| 融资现金流 | 222000.00 | 284000.00 | 1.63M | 110.39M | 8.71M |
| 自由现金流 | -10.78M | -4.31M | -7.67M | -5.77M | -10.12M |
| 现金流充裕率 | -16361.76% | - | -90666.67% | - | -122518.18% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -102000.00 | 0.0000 | -12000.00 | - | - |